BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Seattle - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Seattle
X-ORIGINAL-URL:https://scienceinseattle.com
X-WR-CALDESC:Events for Science in Seattle
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200407T180000
DTEND;TZID=America/Vancouver:20200407T193000
DTSTAMP:20260404T010636
CREATED:20200225T165400Z
LAST-MODIFIED:20200225T165400Z
UID:26496-1586282400-1586287800@scienceinseattle.com
SUMMARY:Hack the Performance Review\, with Collaborator: Success Bully
DESCRIPTION:We are at that time of year where we begin to evaluate our personal and professional goals. Performance reviews often produce a roller coaster of emotions; excitement if you are on a promotion track\, and possible dread if you are unclear on where you stand. At review time\, you receive lots of feedback on WHAT needs to be accomplished by the next cycle. The part that is missing is HOW you will accomplish the goals. Hosted by our collaborator Success Bully\, this event will provide tips and tricks for successfully navigating your next performance review by elite accountability practice. \nSpeaker \nKeita Williams \nFounder & Chief Strategist of Success Bully
URL:https://scienceinseattle.com/event/hack-the-performance-review-with-collaborator-success-bully-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200408T090000
DTEND;TZID=America/Vancouver:20200408T110000
DTSTAMP:20260404T010636
CREATED:20200330T190906Z
LAST-MODIFIED:20200330T190906Z
UID:8697-1586336400-1586343600@scienceinseattle.com
SUMMARY:Webinar: Deciphering the Cell Cycle - The Role of Cell Cycle Control in Cancer
DESCRIPTION:A fundamental hallmark of cancer is uncontrolled cell division. In an effort to understand this process\, researchers have focused on characterizing the signaling proteins that govern the regulation of the cell cycle. Specific cyclin dependent kinases (CDKs) and their activating cyclin subunits are desirable therapeutic targets because they regulate a cell’s transition through different phases and checkpoints in the cycle\, providing opportunities to block dysregulated cell division and therefore block tumor growth. In recent years\, researchers have seen success with FDA-approved treatments that target CDK4/6 at the G1/S checkpoint of the cell cycle in estrogen receptor-positive and HER2-negative breast cancers. Many clinical trials are ongoing\, not only to test new drugs\, but also to examine the effects of combinatorial therapies on various cancer types. In their presentations\, our speakers will discuss the intricate interactions between key cell-cycle proteins and how therapeutic interventions can target their activity to fight common cancers.\nDuring the webinar viewers will: \n\nHear about exciting advancements in understanding how CDKs regulate cell cycle control\nDiscover how new CDK inhibitors can be used in combination with other therapeutics to target cancer\nLearn about similarities and differences in critical cell cycle signaling pathways in different cancer types\nHave the opportunity to ask questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes \nYou can also view part 1 of this series.
URL:https://scienceinseattle.com/event/webinar-deciphering-the-cell-cycle-the-role-of-cell-cycle-control-in-cancer/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/03/Deciphering-the-cell-cycle-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200408T090000
DTEND;TZID=America/Vancouver:20200408T110000
DTSTAMP:20260404T010636
CREATED:20200330T190906Z
LAST-MODIFIED:20200330T190906Z
UID:25545-1586336400-1586343600@scienceinseattle.com
SUMMARY:Webinar: Deciphering the Cell Cycle - The Role of Cell Cycle Control in Cancer
DESCRIPTION:A fundamental hallmark of cancer is uncontrolled cell division. In an effort to understand this process\, researchers have focused on characterizing the signaling proteins that govern the regulation of the cell cycle. Specific cyclin dependent kinases (CDKs) and their activating cyclin subunits are desirable therapeutic targets because they regulate a cell’s transition through different phases and checkpoints in the cycle\, providing opportunities to block dysregulated cell division and therefore block tumor growth. In recent years\, researchers have seen success with FDA-approved treatments that target CDK4/6 at the G1/S checkpoint of the cell cycle in estrogen receptor-positive and HER2-negative breast cancers. Many clinical trials are ongoing\, not only to test new drugs\, but also to examine the effects of combinatorial therapies on various cancer types. In their presentations\, our speakers will discuss the intricate interactions between key cell-cycle proteins and how therapeutic interventions can target their activity to fight common cancers.\nDuring the webinar viewers will: \n\nHear about exciting advancements in understanding how CDKs regulate cell cycle control\nDiscover how new CDK inhibitors can be used in combination with other therapeutics to target cancer\nLearn about similarities and differences in critical cell cycle signaling pathways in different cancer types\nHave the opportunity to ask questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes \nYou can also view part 1 of this series.
URL:https://scienceinseattle.com/event/webinar-deciphering-the-cell-cycle-the-role-of-cell-cycle-control-in-cancer-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/03/Deciphering-the-cell-cycle-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200408T090000
DTEND;TZID=America/Vancouver:20200408T110000
DTSTAMP:20260404T010636
CREATED:20200330T190906Z
LAST-MODIFIED:20200330T190906Z
UID:26510-1586336400-1586343600@scienceinseattle.com
SUMMARY:Webinar: Deciphering the Cell Cycle - The Role of Cell Cycle Control in Cancer
DESCRIPTION:A fundamental hallmark of cancer is uncontrolled cell division. In an effort to understand this process\, researchers have focused on characterizing the signaling proteins that govern the regulation of the cell cycle. Specific cyclin dependent kinases (CDKs) and their activating cyclin subunits are desirable therapeutic targets because they regulate a cell’s transition through different phases and checkpoints in the cycle\, providing opportunities to block dysregulated cell division and therefore block tumor growth. In recent years\, researchers have seen success with FDA-approved treatments that target CDK4/6 at the G1/S checkpoint of the cell cycle in estrogen receptor-positive and HER2-negative breast cancers. Many clinical trials are ongoing\, not only to test new drugs\, but also to examine the effects of combinatorial therapies on various cancer types. In their presentations\, our speakers will discuss the intricate interactions between key cell-cycle proteins and how therapeutic interventions can target their activity to fight common cancers.\nDuring the webinar viewers will: \n\nHear about exciting advancements in understanding how CDKs regulate cell cycle control\nDiscover how new CDK inhibitors can be used in combination with other therapeutics to target cancer\nLearn about similarities and differences in critical cell cycle signaling pathways in different cancer types\nHave the opportunity to ask questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes \nYou can also view part 1 of this series.
URL:https://scienceinseattle.com/event/webinar-deciphering-the-cell-cycle-the-role-of-cell-cycle-control-in-cancer-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/03/Deciphering-the-cell-cycle-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200409T080000
DTEND;TZID=America/Vancouver:20200410T170000
DTSTAMP:20260404T010636
CREATED:20200326T204321Z
LAST-MODIFIED:20200326T204321Z
UID:8682-1586419200-1586538000@scienceinseattle.com
SUMMARY:Microbiome Symposium
DESCRIPTION:COVID-19 UPDATE: For the health of our attendees\, speakers\, and community\, we are suspending the in-person portion of the symposium. Speaker presentations will occur as scheduled\, in a Webinar format. Instructions for accessing the Webinar will be sent to registered attendees by March 30. The reception and poster session are canceled. \nYou are invited to attend the 2020 Biennial Microbiome Symposium co-hosted by the Fred Hutch Microbiome Research Initiative and the University of Washington’s Center for Microbiome Sciences & Therapeutics (CMiST). The 2020 symposium will feature presentations by local and international investigators involving therapeutics\, HIV and the microbiome\, chemistry and the microbiome\, models of disease\, biostatistics and computational methods\, and the pediatric microbiome. Please join us as we communicate new knowledge\, develop collaborations\, network with colleagues\, and exchange scientific ideas. \nThis symposium is open to faculty\, staff\, and students who hold a position or research affiliation at one of the following organizations: Fred Hutchinson Cancer Research Center\, University of Washington\, Seattle Children’s\, Institute for Systems Biology\, Bill & Melinda Gates Foundation\, and the Benaroya Research Institute.University of Washington’s Center for Microbiome Sciences & Therapeutics
URL:https://scienceinseattle.com/event/microbiome-symposium-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/03/Microbiome-research-symposium-1-min.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200409T080000
DTEND;TZID=America/Vancouver:20200410T170000
DTSTAMP:20260404T010636
CREATED:20200326T204321Z
LAST-MODIFIED:20200326T204321Z
UID:25543-1586419200-1586538000@scienceinseattle.com
SUMMARY:Microbiome Symposium
DESCRIPTION:COVID-19 UPDATE: For the health of our attendees\, speakers\, and community\, we are suspending the in-person portion of the symposium. Speaker presentations will occur as scheduled\, in a Webinar format. Instructions for accessing the Webinar will be sent to registered attendees by March 30. The reception and poster session are canceled. \nYou are invited to attend the 2020 Biennial Microbiome Symposium co-hosted by the Fred Hutch Microbiome Research Initiative and the University of Washington’s Center for Microbiome Sciences & Therapeutics (CMiST). The 2020 symposium will feature presentations by local and international investigators involving therapeutics\, HIV and the microbiome\, chemistry and the microbiome\, models of disease\, biostatistics and computational methods\, and the pediatric microbiome. Please join us as we communicate new knowledge\, develop collaborations\, network with colleagues\, and exchange scientific ideas. \nThis symposium is open to faculty\, staff\, and students who hold a position or research affiliation at one of the following organizations: Fred Hutchinson Cancer Research Center\, University of Washington\, Seattle Children’s\, Institute for Systems Biology\, Bill & Melinda Gates Foundation\, and the Benaroya Research Institute.University of Washington’s Center for Microbiome Sciences & Therapeutics
URL:https://scienceinseattle.com/event/microbiome-symposium-2-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/03/Microbiome-research-symposium-1-min.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200409T080000
DTEND;TZID=America/Vancouver:20200410T170000
DTSTAMP:20260404T010636
CREATED:20200326T204321Z
LAST-MODIFIED:20200326T204321Z
UID:26508-1586419200-1586538000@scienceinseattle.com
SUMMARY:Microbiome Symposium
DESCRIPTION:COVID-19 UPDATE: For the health of our attendees\, speakers\, and community\, we are suspending the in-person portion of the symposium. Speaker presentations will occur as scheduled\, in a Webinar format. Instructions for accessing the Webinar will be sent to registered attendees by March 30. The reception and poster session are canceled. \nYou are invited to attend the 2020 Biennial Microbiome Symposium co-hosted by the Fred Hutch Microbiome Research Initiative and the University of Washington’s Center for Microbiome Sciences & Therapeutics (CMiST). The 2020 symposium will feature presentations by local and international investigators involving therapeutics\, HIV and the microbiome\, chemistry and the microbiome\, models of disease\, biostatistics and computational methods\, and the pediatric microbiome. Please join us as we communicate new knowledge\, develop collaborations\, network with colleagues\, and exchange scientific ideas. \nThis symposium is open to faculty\, staff\, and students who hold a position or research affiliation at one of the following organizations: Fred Hutchinson Cancer Research Center\, University of Washington\, Seattle Children’s\, Institute for Systems Biology\, Bill & Melinda Gates Foundation\, and the Benaroya Research Institute.University of Washington’s Center for Microbiome Sciences & Therapeutics
URL:https://scienceinseattle.com/event/microbiome-symposium-2-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/03/Microbiome-research-symposium-1-min.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200409T090000
DTEND;TZID=America/Vancouver:20200409T100000
DTSTAMP:20260404T010636
CREATED:20200407T223037Z
LAST-MODIFIED:20200407T223037Z
UID:8803-1586422800-1586426400@scienceinseattle.com
SUMMARY:#HowToScienceAtHome Twitter Chat
DESCRIPTION:Join the Allen Institute (@alleninstitute) on 4/9 @ 9AM(PT) for a Twitter Chat: #HowToScienceAtHome \nWe are inviting science researchers\, educators\, students\, and organizations with online resources to share their tips\, discuss challenges\, and support each other. Follow along with our discussion prompts to share your tips\, stories\, and resources using the hashtag #HowToScienceAtHome.
URL:https://scienceinseattle.com/event/howtoscienceathome-twitter-chat/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/twitterchatpromo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200409T090000
DTEND;TZID=America/Vancouver:20200409T100000
DTSTAMP:20260404T010636
CREATED:20200407T223037Z
LAST-MODIFIED:20200407T223037Z
UID:25555-1586422800-1586426400@scienceinseattle.com
SUMMARY:#HowToScienceAtHome Twitter Chat
DESCRIPTION:Join the Allen Institute (@alleninstitute) on 4/9 @ 9AM(PT) for a Twitter Chat: #HowToScienceAtHome \nWe are inviting science researchers\, educators\, students\, and organizations with online resources to share their tips\, discuss challenges\, and support each other. Follow along with our discussion prompts to share your tips\, stories\, and resources using the hashtag #HowToScienceAtHome.
URL:https://scienceinseattle.com/event/howtoscienceathome-twitter-chat-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/twitterchatpromo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200409T090000
DTEND;TZID=America/Vancouver:20200409T100000
DTSTAMP:20260404T010636
CREATED:20200407T223037Z
LAST-MODIFIED:20200407T223037Z
UID:26520-1586422800-1586426400@scienceinseattle.com
SUMMARY:#HowToScienceAtHome Twitter Chat
DESCRIPTION:Join the Allen Institute (@alleninstitute) on 4/9 @ 9AM(PT) for a Twitter Chat: #HowToScienceAtHome \nWe are inviting science researchers\, educators\, students\, and organizations with online resources to share their tips\, discuss challenges\, and support each other. Follow along with our discussion prompts to share your tips\, stories\, and resources using the hashtag #HowToScienceAtHome.
URL:https://scienceinseattle.com/event/howtoscienceathome-twitter-chat-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/twitterchatpromo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200409T140000
DTEND;TZID=America/Vancouver:20200409T150000
DTSTAMP:20260404T010636
CREATED:20200406T214720Z
LAST-MODIFIED:20200406T214720Z
UID:8791-1586440800-1586444400@scienceinseattle.com
SUMMARY:PATH Live Forum: Understanding the Pandemic
DESCRIPTION:In our first discussion with PATH’s two top doctors\, renowned experts in public health and vaccine research and development\, respectively\, we’ll explore questions like: \n– What are the most important aspects of this pandemic that we still don’t understand? \n– Is expedited delivery of therapeutics—or a vaccine—possible on a global scale? \n– How will this new coronavirus affect countries and communities with underfunded and weaker health systems? \nSpeakers: \nDr. David Fleming \, Vice President\, Global Health Programs\, PATH \nDr. David Kaslow\, Vice President\, Essential Medicines Director\, PATH
URL:https://scienceinseattle.com/event/path-live-forum-understanding-the-pandemic/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/PATH-Understanding-COVID19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200409T140000
DTEND;TZID=America/Vancouver:20200409T150000
DTSTAMP:20260404T010636
CREATED:20200406T214720Z
LAST-MODIFIED:20200406T214720Z
UID:25553-1586440800-1586444400@scienceinseattle.com
SUMMARY:PATH Live Forum: Understanding the Pandemic
DESCRIPTION:In our first discussion with PATH’s two top doctors\, renowned experts in public health and vaccine research and development\, respectively\, we’ll explore questions like: \n– What are the most important aspects of this pandemic that we still don’t understand? \n– Is expedited delivery of therapeutics—or a vaccine—possible on a global scale? \n– How will this new coronavirus affect countries and communities with underfunded and weaker health systems? \nSpeakers: \nDr. David Fleming \, Vice President\, Global Health Programs\, PATH \nDr. David Kaslow\, Vice President\, Essential Medicines Director\, PATH
URL:https://scienceinseattle.com/event/path-live-forum-understanding-the-pandemic-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/PATH-Understanding-COVID19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200409T140000
DTEND;TZID=America/Vancouver:20200409T150000
DTSTAMP:20260404T010636
CREATED:20200406T214720Z
LAST-MODIFIED:20200406T214720Z
UID:26518-1586440800-1586444400@scienceinseattle.com
SUMMARY:PATH Live Forum: Understanding the Pandemic
DESCRIPTION:In our first discussion with PATH’s two top doctors\, renowned experts in public health and vaccine research and development\, respectively\, we’ll explore questions like: \n– What are the most important aspects of this pandemic that we still don’t understand? \n– Is expedited delivery of therapeutics—or a vaccine—possible on a global scale? \n– How will this new coronavirus affect countries and communities with underfunded and weaker health systems? \nSpeakers: \nDr. David Fleming \, Vice President\, Global Health Programs\, PATH \nDr. David Kaslow\, Vice President\, Essential Medicines Director\, PATH
URL:https://scienceinseattle.com/event/path-live-forum-understanding-the-pandemic-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/PATH-Understanding-COVID19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200410T120000
DTEND;TZID=America/Vancouver:20200410T130000
DTSTAMP:20260404T010636
CREATED:20200403T203135Z
LAST-MODIFIED:20200403T203135Z
UID:8773-1586520000-1586523600@scienceinseattle.com
SUMMARY:Fundamentals for Startups: Negotiating Startup Life through a Crisis
DESCRIPTION:In this conversation\, Dan Rosen\, Xiao Wang and Ken Myer will dive into the challenges and opportunities of navigating a startup through the COVID-19 crisis. As an experienced investor and chairman of Alliance of Angels\, Dan has a wealth of experience investing and advising startup companies in a variety of industries. Xiao Wang is President and CEO of Boundless Immigration\, a technology startup whose mission is to empower families to navigate the immigration system. Not surprisingly\, the COVID-19 crisis has Xiao and his team navigating their own unique business challenges. Ken Myer is an interim executive who helps companies navigate challenging business transitions and is a lecturer on leadership and a commercialization adviser at the UW. Using an interview-style format through a Zoom online video conference\, we’ll explore the implications of the COVID-19 crisis on startup teams and leaders. \nFormat\nFundamentals for Startups is a weekly one-hour lecture series featuring notable experts who share startup-related information\, experience\, and insights with our entrepreneurial community. From raising capital to scaling to exit strategies\, these seasoned guest speakers deliver valuable content designed to help startups and entrepreneurs thrive. Lectures are typically 30-40 mins\, followed by open Q&A. \nEach lecture is archived on CoMotion’s Startup Training Videos page. \nThese lectures are open to the public and you do not have to be currently affiliated with the UW or a startup to join. Please register at the link below for Zoom access information.  We hope you can join us! \nhttps://washington.zoom.us/meeting/register/v5Ysfu2qpjwuTUsSYXd1tqry53YpmnNjZw
URL:https://scienceinseattle.com/event/fundamentals-for-startups-negotiating-startup-life-through-a-crisis/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/Fundamentals-for-startups.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200410T120000
DTEND;TZID=America/Vancouver:20200410T130000
DTSTAMP:20260404T010636
CREATED:20200403T203135Z
LAST-MODIFIED:20200403T203135Z
UID:25552-1586520000-1586523600@scienceinseattle.com
SUMMARY:Fundamentals for Startups: Negotiating Startup Life through a Crisis
DESCRIPTION:In this conversation\, Dan Rosen\, Xiao Wang and Ken Myer will dive into the challenges and opportunities of navigating a startup through the COVID-19 crisis. As an experienced investor and chairman of Alliance of Angels\, Dan has a wealth of experience investing and advising startup companies in a variety of industries. Xiao Wang is President and CEO of Boundless Immigration\, a technology startup whose mission is to empower families to navigate the immigration system. Not surprisingly\, the COVID-19 crisis has Xiao and his team navigating their own unique business challenges. Ken Myer is an interim executive who helps companies navigate challenging business transitions and is a lecturer on leadership and a commercialization adviser at the UW. Using an interview-style format through a Zoom online video conference\, we’ll explore the implications of the COVID-19 crisis on startup teams and leaders. \nFormat\nFundamentals for Startups is a weekly one-hour lecture series featuring notable experts who share startup-related information\, experience\, and insights with our entrepreneurial community. From raising capital to scaling to exit strategies\, these seasoned guest speakers deliver valuable content designed to help startups and entrepreneurs thrive. Lectures are typically 30-40 mins\, followed by open Q&A. \nEach lecture is archived on CoMotion’s Startup Training Videos page. \nThese lectures are open to the public and you do not have to be currently affiliated with the UW or a startup to join. Please register at the link below for Zoom access information.  We hope you can join us! \nhttps://washington.zoom.us/meeting/register/v5Ysfu2qpjwuTUsSYXd1tqry53YpmnNjZw
URL:https://scienceinseattle.com/event/fundamentals-for-startups-negotiating-startup-life-through-a-crisis-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/Fundamentals-for-startups.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200410T120000
DTEND;TZID=America/Vancouver:20200410T130000
DTSTAMP:20260404T010636
CREATED:20200403T203135Z
LAST-MODIFIED:20200403T203135Z
UID:26517-1586520000-1586523600@scienceinseattle.com
SUMMARY:Fundamentals for Startups: Negotiating Startup Life through a Crisis
DESCRIPTION:In this conversation\, Dan Rosen\, Xiao Wang and Ken Myer will dive into the challenges and opportunities of navigating a startup through the COVID-19 crisis. As an experienced investor and chairman of Alliance of Angels\, Dan has a wealth of experience investing and advising startup companies in a variety of industries. Xiao Wang is President and CEO of Boundless Immigration\, a technology startup whose mission is to empower families to navigate the immigration system. Not surprisingly\, the COVID-19 crisis has Xiao and his team navigating their own unique business challenges. Ken Myer is an interim executive who helps companies navigate challenging business transitions and is a lecturer on leadership and a commercialization adviser at the UW. Using an interview-style format through a Zoom online video conference\, we’ll explore the implications of the COVID-19 crisis on startup teams and leaders. \nFormat\nFundamentals for Startups is a weekly one-hour lecture series featuring notable experts who share startup-related information\, experience\, and insights with our entrepreneurial community. From raising capital to scaling to exit strategies\, these seasoned guest speakers deliver valuable content designed to help startups and entrepreneurs thrive. Lectures are typically 30-40 mins\, followed by open Q&A. \nEach lecture is archived on CoMotion’s Startup Training Videos page. \nThese lectures are open to the public and you do not have to be currently affiliated with the UW or a startup to join. Please register at the link below for Zoom access information.  We hope you can join us! \nhttps://washington.zoom.us/meeting/register/v5Ysfu2qpjwuTUsSYXd1tqry53YpmnNjZw
URL:https://scienceinseattle.com/event/fundamentals-for-startups-negotiating-startup-life-through-a-crisis-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/Fundamentals-for-startups.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200414T100000
DTEND;TZID=America/Vancouver:20200414T110000
DTSTAMP:20260404T010636
CREATED:20200413T151552Z
LAST-MODIFIED:20200413T151552Z
UID:8831-1586858400-1586862000@scienceinseattle.com
SUMMARY:Distance Learning for Cell Biology: A Ready-to-Use Virtual Laboratory for Teaching Mitosis
DESCRIPTION:As part of our mission to support open science\, the Allen Institute shares all of the data we generate freely for anyone to use in research or teaching. This enables students to conduct online experiments for distance learning. In this webinar\, you’ll learn how to run a ready-to-use\, fully online virtual lab experiment with your students.
URL:https://scienceinseattle.com/event/distance-learning-for-cell-biology-a-ready-to-use-virtual-laboratory-for-teaching-mitosis/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/2020_webinar_banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200414T100000
DTEND;TZID=America/Vancouver:20200414T110000
DTSTAMP:20260404T010636
CREATED:20200413T151552Z
LAST-MODIFIED:20200413T151552Z
UID:25556-1586858400-1586862000@scienceinseattle.com
SUMMARY:Distance Learning for Cell Biology: A Ready-to-Use Virtual Laboratory for Teaching Mitosis
DESCRIPTION:As part of our mission to support open science\, the Allen Institute shares all of the data we generate freely for anyone to use in research or teaching. This enables students to conduct online experiments for distance learning. In this webinar\, you’ll learn how to run a ready-to-use\, fully online virtual lab experiment with your students.
URL:https://scienceinseattle.com/event/distance-learning-for-cell-biology-a-ready-to-use-virtual-laboratory-for-teaching-mitosis-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/2020_webinar_banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200414T100000
DTEND;TZID=America/Vancouver:20200414T110000
DTSTAMP:20260404T010636
CREATED:20200413T151552Z
LAST-MODIFIED:20200413T151552Z
UID:26521-1586858400-1586862000@scienceinseattle.com
SUMMARY:Distance Learning for Cell Biology: A Ready-to-Use Virtual Laboratory for Teaching Mitosis
DESCRIPTION:As part of our mission to support open science\, the Allen Institute shares all of the data we generate freely for anyone to use in research or teaching. This enables students to conduct online experiments for distance learning. In this webinar\, you’ll learn how to run a ready-to-use\, fully online virtual lab experiment with your students.
URL:https://scienceinseattle.com/event/distance-learning-for-cell-biology-a-ready-to-use-virtual-laboratory-for-teaching-mitosis-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/2020_webinar_banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260404T010636
CREATED:20200330T211405Z
LAST-MODIFIED:20200330T211405Z
UID:8725-1587373200-1587376800@scienceinseattle.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinseattle.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability/
LOCATION:Online
ORGANIZER;CN="STEMCELL Technologies":MAILTO:info@stemcell.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260404T010636
CREATED:20200330T211405Z
LAST-MODIFIED:20200330T211405Z
UID:25547-1587373200-1587376800@scienceinseattle.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinseattle.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability-2/
LOCATION:Online
ORGANIZER;CN="STEMCELL Technologies":MAILTO:info@stemcell.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260404T010636
CREATED:20200330T211405Z
LAST-MODIFIED:20200330T211405Z
UID:26512-1587373200-1587376800@scienceinseattle.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinseattle.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability-3/
LOCATION:Online
ORGANIZER;CN="STEMCELL Technologies":MAILTO:info@stemcell.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260404T010636
CREATED:20200417T210237Z
LAST-MODIFIED:20200417T210237Z
UID:8934-1587384000-1587387600@scienceinseattle.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinseattle.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260404T010636
CREATED:20200417T210237Z
LAST-MODIFIED:20200417T210237Z
UID:25563-1587384000-1587387600@scienceinseattle.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinseattle.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260404T010636
CREATED:20200417T210237Z
LAST-MODIFIED:20200417T210237Z
UID:26528-1587384000-1587387600@scienceinseattle.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinseattle.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T100000
DTEND;TZID=America/Vancouver:20200421T110000
DTSTAMP:20260404T010636
CREATED:20200326T222814Z
LAST-MODIFIED:20200326T222814Z
UID:8687-1587463200-1587466800@scienceinseattle.com
SUMMARY:North American Vascular Biology Organization (NAVBO) Online Mini-Symposia
DESCRIPTION:An online mini-symposium featuring four presentations:\n\nRenal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern)\nInhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago)\nDach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University)\nPro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinseattle.com/event/north-american-vascular-biology-organization-navbo-online-mini-symposia/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/03/NAVBO.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T100000
DTEND;TZID=America/Vancouver:20200421T110000
DTSTAMP:20260404T010636
CREATED:20200326T222814Z
LAST-MODIFIED:20200326T222814Z
UID:25544-1587463200-1587466800@scienceinseattle.com
SUMMARY:North American Vascular Biology Organization (NAVBO) Online Mini-Symposia
DESCRIPTION:An online mini-symposium featuring four presentations:\n\nRenal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern)\nInhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago)\nDach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University)\nPro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinseattle.com/event/north-american-vascular-biology-organization-navbo-online-mini-symposia-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/03/NAVBO.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T100000
DTEND;TZID=America/Vancouver:20200421T110000
DTSTAMP:20260404T010636
CREATED:20200326T222814Z
LAST-MODIFIED:20200326T222814Z
UID:26509-1587463200-1587466800@scienceinseattle.com
SUMMARY:North American Vascular Biology Organization (NAVBO) Online Mini-Symposia
DESCRIPTION:An online mini-symposium featuring four presentations:\n\nRenal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern)\nInhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago)\nDach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University)\nPro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinseattle.com/event/north-american-vascular-biology-organization-navbo-online-mini-symposia-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/03/NAVBO.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T120000
DTEND;TZID=America/Vancouver:20200421T130000
DTSTAMP:20260404T010636
CREATED:20200316T214238Z
LAST-MODIFIED:20200316T214238Z
UID:8585-1587470400-1587474000@scienceinseattle.com
SUMMARY:Women in Bio National Webinar: Fundraising Boot Camp for Life Science Startups: Successful Partnering
DESCRIPTION:Booking a full schedule of meetings at any conference requires understanding the platform and how to execute a strategic plan\, utilizing all the tools and resources available to you. You already know how to identify investors you match with and have your story straight. Now you must book as many meetings as possible. As the second webinar in a three-part series\, this workshop will discuss how to introduce your company to an investor and how to request a meeting. You are also going to learn the follow-up processes that make the argument of why you are investable and why an investor should meet with you.\n \nSeries Description \n\nIn preparation for Partnering with Investors and the Women In Bio Sponsored Pitch Challenge at RESI San Diego\, Life Science Nation (LSN) and Women In Bio’s Entrepreneur Center will offer three webinars: Messaging and Branding\, Successful Partnering\, and a Fundraising Bootcamp. \n\nWho should attend? \nAnyone considering or actively developing therapeutic\, medical device\, diagnostic\, or digital health technologies and raising their seed\, series A\, or series B\, up to $50 million\, to complete any early stage of development leading to commercialization. \n\nWhat you will learn? \nOur proven methodology for matching early stage life science companies with investors based on fit (sector\, subsector\, indication\, and stage of development) and getting your story straight for navigating the fundraising ecosystem and generating more compelling connections with investors. \n\nAbout Life Science Nation \nLife Science Nation (LSN) is a global partnering ecosystem that allows early-stage companies with compelling technology assets to get plugged into the early-stage investor and channel partner’s radars with minimal cost and a big ROI. LSN is a global matching platform for early-stage buyers and sellers across the domains of Drugs\, Devices\, Diagnostics and Digital Health – the “4 Ds”. LSN curates two databases: a buy-side of global cross-border early-stage investors/partners and a sell-side of global cross-domain technology assets. LSN also offers a sourcing and ranking service for clients who need to source and rank technology assets for channel\, pipeline and portfolio development. LSN owns and operates the Redefining Early Stage Investments (RESI) conference series\, a funding superstructure that runs five times a year during J.P. Morgan in San Francisco (January)\, alongside BIO Europe (March)\, alongside BIO U.S (June)\, Boston (September) and Asia (November). LSN also owns and operates the Focus on Cures Accelerator (FOC) that provides startups a Boston-based footprint and helps them develop and execute a global investor and channel partner strategy. Learn more at www.lifesciencenation.com \n  \nSpeaker Bio \n\nBryanna Allison\, Business Development Manager RESI Conference Series\n\nWalk-Ins Accepted? \nWalk-ins are not accepted – be sure to register early! \n\nPricing Information* \nMembers: Free \nNon-Members/Free Unlimited Guest Members*: $30 \n*To access the Member rate\, click here to purchase a WIB membership. \n*Our webinar will take place at GoToWebinar. National staff will handle the registration through GoToWebinar. You will receive your join link from GoToWebinar prior to the event.\n \n  \nEvent Capacity \n500 \n  \nRegistration Deadline \nApril 20\, 2020 \n\nEvent Date/Time \nApril 21\, 2020 \n12:00 p.m. – 1:00 p.m. EST* \n*- Please note this webinar’s time is listed in Eastern Standard Time. (The webinar begins promptly at 12:00 p.m.) \nWebinar recording will be mailed out to all registrants and will be available in our members’ only webinar library a few days after the event. WIB Members can enjoy viewing all WIB webinars in our Members’ Only Video Library here.  \n  \nVenue \nGoToWebinar–your join link will be e-mailed to you from GoToWebinar prior to the event
URL:https://scienceinseattle.com/event/women-in-bio-national-webinar-fundraising-boot-camp-for-life-science-startups-successful-partnering/
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2019/06/Women-in-Bio.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T120000
DTEND;TZID=America/Vancouver:20200421T130000
DTSTAMP:20260404T010636
CREATED:20200316T214238Z
LAST-MODIFIED:20200316T214238Z
UID:25537-1587470400-1587474000@scienceinseattle.com
SUMMARY:Women in Bio National Webinar: Fundraising Boot Camp for Life Science Startups: Successful Partnering
DESCRIPTION:Booking a full schedule of meetings at any conference requires understanding the platform and how to execute a strategic plan\, utilizing all the tools and resources available to you. You already know how to identify investors you match with and have your story straight. Now you must book as many meetings as possible. As the second webinar in a three-part series\, this workshop will discuss how to introduce your company to an investor and how to request a meeting. You are also going to learn the follow-up processes that make the argument of why you are investable and why an investor should meet with you.\n \nSeries Description \n\nIn preparation for Partnering with Investors and the Women In Bio Sponsored Pitch Challenge at RESI San Diego\, Life Science Nation (LSN) and Women In Bio’s Entrepreneur Center will offer three webinars: Messaging and Branding\, Successful Partnering\, and a Fundraising Bootcamp. \n\nWho should attend? \nAnyone considering or actively developing therapeutic\, medical device\, diagnostic\, or digital health technologies and raising their seed\, series A\, or series B\, up to $50 million\, to complete any early stage of development leading to commercialization. \n\nWhat you will learn? \nOur proven methodology for matching early stage life science companies with investors based on fit (sector\, subsector\, indication\, and stage of development) and getting your story straight for navigating the fundraising ecosystem and generating more compelling connections with investors. \n\nAbout Life Science Nation \nLife Science Nation (LSN) is a global partnering ecosystem that allows early-stage companies with compelling technology assets to get plugged into the early-stage investor and channel partner’s radars with minimal cost and a big ROI. LSN is a global matching platform for early-stage buyers and sellers across the domains of Drugs\, Devices\, Diagnostics and Digital Health – the “4 Ds”. LSN curates two databases: a buy-side of global cross-border early-stage investors/partners and a sell-side of global cross-domain technology assets. LSN also offers a sourcing and ranking service for clients who need to source and rank technology assets for channel\, pipeline and portfolio development. LSN owns and operates the Redefining Early Stage Investments (RESI) conference series\, a funding superstructure that runs five times a year during J.P. Morgan in San Francisco (January)\, alongside BIO Europe (March)\, alongside BIO U.S (June)\, Boston (September) and Asia (November). LSN also owns and operates the Focus on Cures Accelerator (FOC) that provides startups a Boston-based footprint and helps them develop and execute a global investor and channel partner strategy. Learn more at www.lifesciencenation.com \n  \nSpeaker Bio \n\nBryanna Allison\, Business Development Manager RESI Conference Series\n\nWalk-Ins Accepted? \nWalk-ins are not accepted – be sure to register early! \n\nPricing Information* \nMembers: Free \nNon-Members/Free Unlimited Guest Members*: $30 \n*To access the Member rate\, click here to purchase a WIB membership. \n*Our webinar will take place at GoToWebinar. National staff will handle the registration through GoToWebinar. You will receive your join link from GoToWebinar prior to the event.\n \n  \nEvent Capacity \n500 \n  \nRegistration Deadline \nApril 20\, 2020 \n\nEvent Date/Time \nApril 21\, 2020 \n12:00 p.m. – 1:00 p.m. EST* \n*- Please note this webinar’s time is listed in Eastern Standard Time. (The webinar begins promptly at 12:00 p.m.) \nWebinar recording will be mailed out to all registrants and will be available in our members’ only webinar library a few days after the event. WIB Members can enjoy viewing all WIB webinars in our Members’ Only Video Library here.  \n  \nVenue \nGoToWebinar–your join link will be e-mailed to you from GoToWebinar prior to the event
URL:https://scienceinseattle.com/event/women-in-bio-national-webinar-fundraising-boot-camp-for-life-science-startups-successful-partnering-2/
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2019/06/Women-in-Bio.png
END:VEVENT
END:VCALENDAR